Recurrent wheezing illness in preschool-aged children: Assessment and management in primary care practice

Postgraduate Medicine

Volumn 121, Issue 5, 2009, Pages 48-55

  Bloomberg, Gordon R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Inhaled corticosteroid; Montelukast; Pediatrics; Preschool aged children; Wheezing

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MONTELUKAST; PLACEBO;

ALLERGY; ANAMNESIS; ASTHMA; CHILD; DRUG DOSE REDUCTION; DRUG MEGADOSE; HUMAN; PATIENT CARE; PATIENT MONITORING; PHYSICIAN; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIMARY CARE PHYSICIAN; PRIMARY MEDICAL CARE; RECURRENT DISEASE; REVIEW; WHEEZING;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; CAUSALITY; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; EUROPE; FEMALE; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; MALE; PREDICTIVE VALUE OF TESTS; PREDNISOLONE; PRIMARY HEALTH CARE; QUINOLINES; RECURRENCE; RESPIRATORY SOUNDS; RISK ASSESSMENT; TERMINOLOGY AS TOPIC; UNITED STATES;

EID: 78649272686     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2009.09.2052     Document Type: Review

References (26)

1. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of Childhood Asthma in the United States, 1980-2007. Pediatrics. 2009;123(Suppl 3):S131-S145.
2. Akinbami LJ. The State of childhood asthma, United States, 1980-2005. Hyattsville, MD: National Center for Health Statistics; 2006. Report No. 381.
3. Bisgaard H, Szefler S. Prevalence of asthma-like symptoms in young children. Pediatr Pulmonal. 2007;42(8):723-728.
4. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332(3):133-138.
5. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ 3rd, O'Fallon WM, Silverstein MD. A community-based study of epidemiology of asthma incidence rates, 1964-1983. Am Rev Respir Dis. 1992;146(4):888-894.
6. Gelfand EW. Pediatric asthma: a different disease. Proc Am Thorac Soc. 2009;6(3):278-282.
7. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Summary Report 2007. J Allergy Clin Immunol. 2007;120(5):S93-S138.
8. Brand PL, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32(4):1096-1110.
9. Kaditis A, Winnie G, Syrogiannopoulos A. Anti-inflammatory pharmacotherapy for wheezing in preschool children. Pediat Pulmonol. 2007;42(5):407-420.
10. A plea to abandon asthma as a disease concept. Lancet. 2006;368(9537):705.
11. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354(19):1985-1997.
12. Castro-Rodriguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162(4 pt 1):1403-1406.
13. Kurukulaaratchy RJ, Fenn MH, Waterhouse LM, Matthews SM, Holgate ST, Arshad SH. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy. 2003;33(5):573-578.
14. Illi S, von Mutius E, Lau S, Niggemann B, Grüber C, Wahn U. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368(9537):763-770.
15. Cane RS, McKenzie SA. Parents' interpretations of children's respiratory symptoms on video. Arh Dis Chil. 2001;84(1):31-34.
16. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354(19):1998-2005.
17. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate m Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet. 2006;368(9537):754-762.
18. Bacharier LB, Phillips BR, Zeiger RS, et al. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J All Clin Immun. 2008;122(6):1127- 1135.
19. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360(4):339-353.
20. Rachelefsky G. Inhaled corticosteroids and asthma control in children: assessing impairment and risk. Pediatrics. 2009;123(1):353-366.
21. Expert Panel Report 3 (EPR-3). Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. J Allergy Clin Immunol. 2007;120(5):S94-S138.
22. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L. The effect of montelukast on bronchial hyperreactivity in preschool children. Chest. 2007;131(1):180-186.
23. Bisgaard H, Nielsen KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med. 2000;162(1):187-190.
24. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics. 2001;108(3):E48.
25. Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171(4):315-322.
26. Robertson CF, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med. 2007;175(4):323-329.